We report a rare case of ALK fusion–positive lung adenocarcinoma with concurrent high programmed death-ligand 1 (PD-L1) expression and a Bcl-2-like protein 11 (BIM) deletion polymorphism. This evidence concerns the gene ALK and lung adenocarcinoma.